Nakayama et al. [18] retrospectively investigated ATP7B expression in primary OC and its association with the chemotherapeutic response, finding that patients with ATP7B-positive carcinomas (30% of patients) had worse overall survival than those with ATP7B-negative tumors. Here, ATP7B is linked to carcinoma.